NHS advisory body, National Institute for Health and Care Excellence, states that therapy should only be used for research.
Some private clinics in the UK and US, however, continue to offer it.
Laser rejuvenation involves inserting a probe into the vagina to heat and modify or reshape surrounding tissue.
Clinics claim that the body's healing process is triggered by deliberately injuring tissue. increase natural lubrication and restore sexual gratification.
Nonsurgical treatment can be completed over a lunch hour but is not entirely risk-free, officials say.
The target the US regulator has previously said it is " deeply concerned "that women may be harmed by the procedure.
Some who have suffered from it have had vaginal burns and scarring.
The research, described in the Journal of the American Medical Association, is one of the larger studies to independently examine therapy using the "gold standard" design of a clinical trial.
NICE requested this type of work, to determine if the therapy is safe and beneficial enough to be recommended for further use. large in the NHS.
Australian researchers, not funded by the industry, randomized 85 women to receive either the laser treatment or a placebo procedure - where the probe was inserted but the " required dose of undelivered laser energy.
No serious side effects were recorded - but during the year of follow-up there was also no noticeable difference between the two groupsin terms of improving symptoms.
An accompanying editorial in JAMA compared the laser therapy situation to the recent fear of vaginal mesh, when some women were injured by a later interrupted procedure due to safety concerns .
The authors, Drs Marisa Adelman and Ingrid Nygaard, of the University of Utah School of Medicine, said: "The widespread clinical use of vaginal laser therapy, followed by the Increase in the number of adverse event reports and warnings from the FDA [US Food and Drug Administration], saidcarried an unhappy feeling of dejà vu.
"After a rush in the market for vaginal mesh products for the management of pelvic organ prolapse prior to the completion of rigorous randomized trials, these products are no longer marketed as an au. United States.
"Although marketing before the availability of evidence demonstrating efficacy and safety may be associated with short-term benefits for companies and clinicians, this approach closes any window of opportunity to really know which individuals, if any, are benefiting from treatment, as well as those at increased risk of harm. "
Former British Menopause Society president and spokesperson Tim Hillard, consulting gynecologist in Dorset, said: 'This is the kind of study we have been waiting for.
“This is one of the largest randomized trials and is not industry funded.
"CelIt really reinforces the fact that doctors should only offer this therapy in clinical trials to gather more evidence. "
New treatments for menopause symptoms were needed and deserved to be. to be investigated, Mr Hillard said.
"Symptoms like vaginal dryness, itching and discomfort or pain during sex are very common and can be very distressing for women. women "he said.
" It can be difficult to talk about it.
"A lot of women put up with it and don't seek advice - but there are treatments that can help and there are specialists who can advise.
- Most women will reach menopause between the ages of 45 and 55
- Symptoms can start months or even years before your period stops completely and continuesfor years.
- Hot flashes, night sweats, vaginal dryness, mood changes and difficulty sleeping are common
- Doctors may take a dose blood to measure for hormone levels and may refer patients to a menopause specialist
- Hormone replacement therapy or estrogen-based vaginal creams and lubricants may help